Women Advocates For Vaccine Access

SUSTAINABLE IMMUNIZATION FINANCING

FACTSHEET

Nigeria’s under-five mortality

rate has dropped by 41% from

189 to 109 deaths per 1,000

lives birth, between the years

2000 and 2015.

Vaccines contributed greatly

to this progress, especially

measles vaccine, which helped

decrease measles death by

93% in the same time period.

Since 2012, the country has

successfully introduced three

new vaccines in the RI system

(Penta, PCV and IPV) and plans

to introduce four additional

vaccines (Rota, HPV, Men A

and MR) by 2019.

Due to improved vaccine

funding and better supply

chains, Nigeria has not

recorded any vaccine stock out

in the last three years.

Nigeria has made good progress on routine immunization (RI); these gains must be sustained.

Three new vaccine were introduced in 3 years and more vaccine introductions areplanned

Penta Phase 1

Penta Phase 2 PCV 1 PCV 2

SwitchtOPV to

bOPV

2nd dose Measles

Rota

2012 2013 2014 2015 2016 2017 2018 2019 2020 2021

IPV

PCV 3

HPVroutine

Switch TTto Td

Men A routine

Key

Completed

Planned (cMYP)

Despite recent progress, many children still dropout or are left out of the vaccine programme

Too many children dropout: Among one-year-

olds, only one in four received all required

vaccines.

Too many children are left out: As much as one in five one-year-olds received no vaccine at all.

Most of the leading causes of child deaths (such as pneumonia, diarrhoea, meningitis, and measles) are vaccine preventable, but not all children get these vaccines. We must all raise our voices to ensure no child is left behind.

Diseases that can be prevented by vaccines

Polio

Hepatitis B

Pneumonia

Measles

Meningitis

Whooping Cough

Yellow Fever

Ear Infections

Septicaemia

Diphtheria

Blood Infections

Tetanus

Tuberculosis

#NigFundVaccines

Source: cMYP 2016-2020

Gavi Transitionbeings

Last year of

Gavi support

SwitchMeaslesto MR

[1,2]

[3]

[4]

#VaccineGoodOh#VaccineGoodOh

[4]

Current RI schedule: Getting vaccinated on time is very important. By their first birthday, children should have had 7 clinic visits to complete required vaccines and supplements.

Visit Age of child Vaccines or supplements given

1st visit OPV , BCG, HBV00At birth

2nd visit 1 ½ months (6 weeks) OPV , Penta , PCV11 1

3rd visit 2 ½ months (10 weeks) OPV , Penta , PCV22 2

4th visit 3 ½ months (14 weeks) OPV , Penta , PCV IPV3, 3 3

6 months Vitamin A

9 months Measles, Yellow Fever vaccines

5th visit

6th visit

7th visit 12 months Vitamin A

April, 2017

Vaccine financing is not just expenditure, but wise investments that yield health, economic and social benefits.

Adding (Rota, HPV, Men A and MR) vaccines

into the current RI schedule, can save an

additional 1.2million lives between 2015 and

2020.

A recent research carried out in 94 low and

middle income countries shows that spending

on immunization can yield 16 to 44 times

return on investment by saving money from

treatment cost, lost income and productivity

loss.

Without increased funding for vaccines,

immunization services in public facilities may

be affected, less privileged children may loose

access to immunization services due to inability

to pay for it elsewhere.

Nigeria's transition out of Gavi support creates a huge financial gap for the immunisation program

In the past few years, the federal budget for vaccines

has been inadequate. Nigeria is relying more and more

on donors and loans to support vaccines procurement

to avoid stock outs.

Following the GDP rebasing, Nigeria has risen above the

Gavi eligibility threshold and in 2017, commenced

transition out of Gavi support. This means that

government will gradually take more responsibility for

funding its vaccine program till it is fully self-financing by

2022.

Over the next five years, Nigeria’s immunization

programme will loss millions of dollars in funding

support from Gavi. This transition creates huge funding

gaps that must be filled. Government cannot do it alone,

we all must join hands to ensure sustainable

immunization financing.

[6]

[5]

WAVA Champions as influential voices can support increased vaccine uptake and sustainable financing in Nigeria

WAVA Vaccine Champions can:

· Speak out for sustainable immunization financing

through press briefs, op-eds, articles and posts using

new and traditional print and audio-visual media

· Integrate immunization into their current advocacy

efforts or campaigns. For example, immunization

can be a component of maternal health or cancer

awareness activities.

· Influence colleagues and spouses who are critical

stakeholders to ensure vaccine programmes are

funded. For example, legislators and state governors

can make laws and allocate adequate budgets for

immunization.

· Mobilize their constituencies - for example market

women and the media - to push for adequate

funding for immunization programmes

· Identify evidence or technical resources to support

advocacy for sustainable immunization financing.

· Collaborate among themselves to strengthen each

others efforts by sharing and pooling resources.

· Collaborate with WAVA member organization in

your State to synergize or support their advocacy for

sustainable immunisation financing.

WAVA Members can:

· Speak out for sustainable immunization

financing through press briefs, op-eds,

articles and posts using new and traditional

print and audio-visual media

· Engage health facilities at the state and local

government level to determine their needs

and provide real-time updates on

implementation of immunization.

· Track immunization budget appropriation,

release and utilization at the state and local

government level.

· Monitor service delivery and accountability

of primary health care centres.

· Inform and educate communities on the

value of vaccine and routine immunization

services .

· Mobilize communities for increased uptake

of immunization services.

I will vaccinate my baby;

it is the right thing

to do!

Chizoba Wonodi, MBBS, MPH, DrPHNational Convener Women Advocates for Vaccine Access (WAVA)Nigeria Country Director, Johns Hopkins Bloomberg School of Public Health International Vaccine Access Center (IVAC)cwonodi1@jhu.edu; chizobabw@gmail.com+234 810 009 1910

For further Information contact:WAVA Address:

No. 15 Amazon Street, Off Alvan Ikoku Way

Maitama, FCT Abuja.

@Wavaorgwavaorgwww.facebook.com/wavanigeria

info@wavang.org

Direct Consulting & Logistics (DCL) office

Mothers should also get vaccinated to protect themselves and their babies

WHEN TO GIVE EXPECTED DURATION OF PROTECTION

TT/Td1 At first contact or as early as possible in pregnancy

None

TT/Td2 At least 4 weeks after TT/Td1 1-3 years

TT/Td3 At least 6 months after TT/Td2 or during subsequent pregnancy within 3 years.

5 years

TT/Td4 At least 1 year after TT/Td3 or during subsequent pregnancy

10 years

TT/Td5 At least 1 year after TT/Td4 or during subsequent pregnancy

All the childbearing years

Vaccine TT/Td schedule

A total of 5 doses of Tetanus Toxoids Tetanus-Diphteria (TTTd) is what it takes to protect yourself and your baby

References found in this fact sheet can be found at www.wavang.org/resources